Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1798]
News [2687]
Articles [195]
Editorials [1]
Conferences [135]
elearning [13]
Breakthrough announced in treatment of patient with rare type of leukaemia
Breakthrough announced in treatment of patient with rare type of leukaemia
ASCO GI: Ras status predicts response to second-line treatment with panitumumab for metastatic colorectal cancer
ASCO GI: Ras status predicts response to second-line treatment with panitumumab for metastatic colorectal cancer
ASCO GI: New, rationally-based chemotherapy combination appears highly effective in patients with treatment-resistant neuroendocrine tumours
ASCO GI: New, rationally-based chemotherapy combination appears highly effective in patients with treatment...
ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality of life for patients with metastatic gastric cancer
ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality...
UK cancer death rates drop by 20 per cent over 20 years
UK cancer death rates drop by 20 per cent over 20 years
SABCS 2013: Presurgery treatment combination more effective for women with triple-negative breast cancer
SABCS 2013: Presurgery treatment combination more effective for women with triple-negative breast cancer
SABCS 2013: New combination therapy fails to delay progression of advanced breast cancer
SABCS 2013: New combination therapy fails to delay progression of advanced breast cancer
SABCS 2013: New presurgery combination therapy may improve outcomes for women with triple-negative breast cancer
SABCS 2013: New presurgery combination therapy may improve outcomes for women with triple-negative breast cancer
SABCS 2013: Changing chemotherapy not beneficial for metastatic breast cancer patients With elevated circulating tumour cells
SABCS 2013: Changing chemotherapy not beneficial for metastatic breast cancer patients With elevated circulating...
SABCS 2013: Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer
SABCS 2013: Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation